Doxazosin

Product NDC: 71205-690
11-digit product format: 712050690
Labeler code: 71205
Product ID: 71205-690_8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Doxazosin
Dosage form: TABLET
Route: ORAL
Labeler: Proficient Rx LP
Application: ANDA202824
Marketing category: ANDA
Marketing start: 2015-04-22
Substance: DOXAZOSIN MESYLATE
Active strength: 4 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A202824-001	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2014-06-11
A202824-002	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2014-06-11
A202824-003	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2014-06-11
A202824-004	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2014-06-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A202824-001	AB
A202824-002	AB
A202824-003	AB
A202824-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	A202824-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2014-06-11	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A202824-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2014-06-11	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A202824-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2014-06-11	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A202824-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2014-06-11	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	A202824-001	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A202824-002	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A202824-003	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A202824-004	AB	1	`a50c72e98297…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 13 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Doxazosin	DOXAZOSIN	REMEDYREPACK INC.	71815e8f-33ed-4f36-a8ec-d4443151a9d8	2026-07-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	Northwind Health Company, LLC	f2b35586-d550-3fcb-e053-2995a90a3403	2026-01-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
DOXAZOSIN	DOXAZOSIN	direct rx	b57cf33b-e0bd-54e9-e053-2a95a90a5a6a	2025-01-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	Bryant Ranch Prepack	8c0c0345-833b-4a3d-9081-da66b208d750	2024-09-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	Bryant Ranch Prepack	ef8b5534-5939-400a-ad5e-f9ceaefc4097	2024-09-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	Bryant Ranch Prepack	ac4cd22b-2a03-47b6-9eed-550be278f17d	2024-09-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	Accord Healthcare Inc.	2830533c-ccdf-4401-b19c-763eeb1bc0a7	2024-08-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	NuCare Pharmaceuticals, Inc.	40e47e75-6a47-323b-e054-00144ff8d46c	2024-08-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	A-S Medication Solutions	4034fb6d-f55d-4df0-b500-d6a413591f6e	2024-06-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	A-S Medication Solutions	9f67fa58-f623-4145-9e2c-98feee7ca45f	2024-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	NuCare Pharmaceuticals,Inc.	64a243e6-7056-115d-e053-2a91aa0a510f	2024-06-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	NuCare Pharmaceuticals,Inc.	64a19cb1-79fc-8b0b-e053-2a91aa0aaa94	2024-06-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824
Doxazosin	DOXAZOSIN	Proficient Rx LP	8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d	2022-08-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202824 application number: ANDA202824 ndc (product): 71205-690

Additional Listing Data#

Finished product: Yes
Brand name base: Doxazosin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DOXAZOSIN MESYLATE	4 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
86P6PQK0MU	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
197627	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
07a517fc-5845-3816-0f81-0a121804ec9e	Product name	6	20250107
171dd63c-7eea-ede4-c010-4c25ba0a1087	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71205-690-30	Doxazosin	30 in 1 BOTTLE	TABLET	30	1
71205-690-60	Doxazosin	60 in 1 BOTTLE	TABLET	60	1
71205-690-90	Doxazosin	90 in 1 BOTTLE	TABLET	90	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71205-690	DOXAZOSIN TABLET [PROFICIENT RX LP]	1	Current NDC, Legacy NDC, 3 package rows	20220904_8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
86P6PQK0MU	DOXAZOSIN MESYLATE	77883-43-3	DOXAZOSIN MESYLATE
NW1291F1W8	DOXAZOSIN	74191-85-8	Doxazosin

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197627	doxazosin mesylate 4 MG Oral Tablet	PSN	8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d	1
197627	doxazosin 4 MG Oral Tablet	SCD	8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d	1
197627	doxazosin (as doxazosin mesylate) 4 MG Oral Tablet	SY	8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
71205-690-30	71205069030	30 TABLET in 1 BOTTLE (71205-690-30)	30 tablet	2022-08-26	0000-00-00	No	No	Current
71205-690-60	71205069060	60 TABLET in 1 BOTTLE (71205-690-60)	60 tablet	2022-08-26	0000-00-00	No	No	Current
71205-690-90	71205069090	90 TABLET in 1 BOTTLE (71205-690-90)	90 tablet	2022-08-26	0000-00-00	No	No	Current